Home › NDC Lookup › RxCUI directory › RxCUI 861402

Phenoxybenzamine hydrochloride 10 MG Oral Capsule — RxCUI 861402

RxNorm drug concept · Semantic clinical drug
RxCUI 861402 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861402
Official namePhenoxybenzamine hydrochloride 10 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asphenoxybenzamine HCl 10 MG Oral Capsule
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)14 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenoxybenzamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's used to treat a rare condition called pheochromocytoma — a tumor of the adrenal gland that releases sudden surges of stress hormones. Those surges can cause dangerous spikes i...
  • What exactly is phenoxybenzamine used for?
  • Yes, dizziness when standing — called postural hypotension — is one of the most common effects of this medication, and it's actually a sign that the drug is working. To reduce it,...
  • Will I feel dizzy when I stand up? What can I do about it?
📖 Read our full Phenoxybenzamine guide →

🕸️ Concept Web — How Phenoxybenzamine hydrochloride 10 MG Oral Capsul... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Phenoxybenzamine hydrochloride 10 MG Oral Capsule RxCUI 861402

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Phenoxybenzamine 8149
    • Phenoxybenzamine hydrochloride 71512
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dibenzyline 203778
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Phenoxybenzamine Oral Capsule 373346
    • Phenoxybenzamine hydrochloride Oral Capsule 2648133
    • Phenoxybenzamine Oral Product 1157562
    • Phenoxybenzamine Pill 1157563
    • Phenoxybenzamine hydrochloride Oral Product 2662627
    • Phenoxybenzamine hydrochloride Pill 2659899
    • Phenoxybenzamine Oral Capsule [Dibenzyline] 366722
    • Phenoxybenzamine hydrochloride Oral Capsule [Dibenzyline] 2654585
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Phenoxybenzamine hydrochloride 10 MG 861401
    • Phenoxybenzamine hydrochloride 10 MG Oral Capsule [Dibenzyline] 861404
    • Phenoxybenzamine hydrochloride 10 MG [Dibenzyline] 861403

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Phenoxybenzamine hydrochloride 10 MG SCDC · 861401
  • Phenoxybenzamine Oral Capsule SCDF · 373346
  • Phenoxybenzamine hydrochloride Oral Capsule SCDFP · 2648133
  • Phenoxybenzamine Oral Product SCDG · 1157562
  • Phenoxybenzamine Pill SCDG · 1157563
  • Phenoxybenzamine hydrochloride Oral Product SCDGP · 2662627
  • Phenoxybenzamine hydrochloride Pill SCDGP · 2659899

Brand-Name Concepts

  • Phenoxybenzamine hydrochloride 10 MG Oral Capsule [Dibenzyline] SBD · 861404
  • Phenoxybenzamine hydrochloride 10 MG [Dibenzyline] SBDC · 861403
  • Phenoxybenzamine Oral Capsule [Dibenzyline] SBDF · 366722
  • Phenoxybenzamine hydrochloride Oral Capsule [Dibenzyline] SBDFP · 2654585
  • Dibenzyline Oral Product SBDG · 1166948
  • Dibenzyline Pill SBDG · 1166949
  • Dibenzyline BN · 203778

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 861402 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
35573-0473-02 100 CAPSULE in 1 BOTTLE (35573-473-02) PHENOXYBENZAMINE HYDROCHLORIDE Burel Pharmaceuticals, LLC 2023-05-08
59651-0327-01 100 CAPSULE in 1 BOTTLE (59651-327-01) PHENOXYBENZAMINE HYDROCHLORIDE Aurobindo Pharma Limited 2023-05-08
60219-1502-01 100 CAPSULE in 1 BOTTLE (60219-1502-1) Phenoxybenzamine hydrochloride Amneal Pharmaceuticals NY LLC 2020-10-30
70954-0365-10 100 CAPSULE in 1 BOTTLE (70954-365-10) Phenoxybenzamine Hydrochloride Novitium Pharma LLC 2022-07-19
Observed labelers: Amneal Pharmaceuticals NY LLC (1) · Aurobindo Pharma Limited (1) · Burel Pharmaceuticals, LLC (1) · Novitium Pharma LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.